Yeah agree...ultimately word of mouth is going to sell this for us...
When patients realise that their mates, their neighbours, their relatives are deriving success out of this...and its safe....they are going to join the queues.
Got a mate, M1...his mate was 8 out of 10 pain...he luckily got onto the SAS program very recently...he has had 5 out of the 12 initial injections....
His pain has already dropped to a 6...and he reports the sharp pain that he occasional felt has gone
Its these stories that make it for me in addition to the science and the data.
Soon we will enter our new phase....finalisation of clinical data and the big daddy.....commercialisation phase.
My views, don't know when this will play out, there is still risk, dont invest in just one entity, not advice
General OA media and info, page-267
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $142.7K | 723.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 45775 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 18290 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |